Announcements Trials
Browse Landscape

Phase

Phase 4 2Phase 3 2Phase NA 1

Status

Completed 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Other hematologic neoplasm 1Lymphoid 1Breast 1

Conditions

Osteoporosis 6Breast Neoplasms 4Prostatic Neoplasms 3Bone Diseases, Metabolic 2Prostatic Hyperplasia 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Lymphoma 1Leukemia 1Carcinoma, Intraductal, Noninfiltrating 1Breast Carcinoma In Situ 1

Interventions

Zoledronic Acid 3Denosumab 3Vitamin D 2Risedronic Acid 2Letrozole 2Toremifene 1Ibandronic Acid 1Geritol 1Calcium Carbonate 1Calcium 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 3 × Bone Diseases, Metabolic × Risedronic Acid × Clear all
NCT00452439 2020-12-28

A Study of Actonel for the Prevention of Bone Loss

M.D. Anderson Cancer Center

Phase 3 Completed
72 enrolled 8 charts
LymphoidOther hematologic neoplasm

Bone Diseases, Metabolic, Leukemia, Lymphoma, Osteoporosis, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT00859703 2013-10-31

RISAROS

Hospices Civils de Lyon

Phase 3 Completed
20 enrolled
Breast

Bone Diseases, Metabolic, Breast Neoplasms, Osteoporosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡